StreetAlpha
CRISPR Therapeutics AG · SEC Form 4

CRSP Insider Trading

From SEC Form 446 trades in 2 yearsUpdated Nov 19, 2026

Every open market buy and sale of CRISPR Therapeutics AG stock by its officers, directors and 10% owners over the last two years, straight from SEC Form 4 filings. Insiders are only selling over the last 12 months: $0 bought and $17.9M sold.

← CRSP stock page

Insiders are only selling
Bought, 12 months$00 buys · 0 insiders
Sold, 12 months$17.9M23 sales · 6 insiders
Net−$17.9Mbought minus sold
Planned sales62%of sold value, 10b5-1 plans

Buying and selling by month

open market, last 12 months
2025-12: sold $560KDec2026-01: sold $9.1MJan2026-02: sold $477KFeb2026-03: sold $2.8MMarApr2026-05: sold $211KMayJunJulAug2026-09: sold $1.4MSep2026-10: sold $3.5MOctNov
Bought (up)Sold (down)
AI Pro · insider alerts

Get an alert when CRSP insiders trade

We read every Form 4 the moment the SEC posts it and tell you when an CRSP officer, director or 10% owner buys on the open market, or sells $250K or more outside a pre-arranged plan, by email or on your phone.

Insider alerts are part of AI Pro. Start with a free account, then add AI Pro when you want the alerts.

Every CRSP insider trade

2 years · newest first
InsiderTypePriceHeld afterFiled
Oct 19, 2026Samarth KulkarniCEOSale47,837$49.78$2.4M311,899Oct 20Form 4
Oct 14, 2026Simeon GeorgeDirectorSale plan14,514$49.63$720K15,486Oct 16Form 4
Oct 14, 2026Samarth KulkarniCEOSale4,098$49.26$202K259,736Oct 15Form 4
Oct 14, 2026James R. KasingerGeneral Counsel and SecretarySale1,040$49.26$51K95,857Oct 15Form 4
Oct 6, 2026James R. KasingerGeneral Counsel and SecretarySale plan1,990$60.04$119K94,784Oct 8Form 4
Sep 22, 2026James R. KasingerGeneral Counsel and SecretarySale plan10,400$60.24$626K94,784Sep 24Form 4
Sep 17, 2026Ali BehbahaniDirectorSale13,679$57.09$781K16,637Sep 21Form 4
May 29, 2026Naimish PatelChief Medical OfficerSale3,786$55.62$211K19,357Jun 1Form 4
Mar 23, 2026Raju PrasadCFOSale3,708$46.78$173K15,565Mar 24Form 4
Mar 23, 2026Samarth KulkarniCEOSale10,020$46.78$469K255,501Mar 24Form 4
Mar 23, 2026James R. KasingerGeneral Counsel and SecretarySale3,182$46.78$149K94,308Mar 24Form 4
Mar 16, 2026Samarth KulkarniCEOSale10,349$48.26$499K245,834Mar 17Form 4
Mar 16, 2026James R. KasingerGeneral Counsel and SecretarySale3,450$48.26$166K91,240Mar 17Form 4
Mar 16, 2026Raju PrasadCFOSale9,869$48.26$476K13,773Mar 17Form 4
Mar 16, 2026Naimish PatelChief Medical OfficerSale3,150$48.26$152K13,143Mar 17Form 4
🔒 31 more trades. Create a free account or sign in to see them all.

CRSP insider trading FAQ

Are CRSP insiders buying or selling?

Insiders are only selling over the last 12 months. 0 insiders bought $0 of CRSP on the open market in 0 trades, and 6 sold $17.9M in 23 trades, 62% of that under pre-arranged trading plans.

When did an CRSP insider last buy shares?

Douglas A Treco (Director) bought 20,000 shares for $1.1M on Aug 6, 2025, reported on Aug 8, 2025.

When did an CRSP insider last sell shares?

Samarth Kulkarni (CEO) sold 47,837 shares for $2.4M on Oct 19, 2026.

What is a Form 4?

Company officers, directors and owners of more than 10% of the shares must report trades in the company's stock to the SEC on Form 4 within two business days. This page shows open market buys and sales only. Option exercises, stock awards, gifts and shares withheld for taxes are left out, since they are not decisions to buy or sell.

Why do insider sales matter less than buys?

Insiders sell for many reasons, such as taxes, diversification or a home purchase, and many sales are scheduled months ahead under a 10b5-1 trading plan. They buy on the open market mostly when they expect the shares to rise, which is why buying, and especially several insiders buying together, gets more attention.

For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Trades come from SEC Form 4 filings as reported by the insiders. Insiders have two business days to report, so a trade can be a few days old when it appears. See all insider cluster buys.

From SEC Form 4 filings · Not investment advice